Zura Bio Limited (ZURA)
NASDAQ: ZURA · Real-Time Price · USD
6.45
+0.13 (2.06%)
At close: Jan 22, 2026, 4:00 PM EST
6.44
-0.01 (-0.16%)
After-hours: Jan 22, 2026, 7:50 PM EST
Zura Bio Employees
Zura Bio had 30 employees as of December 31, 2024. The number of employees increased by 15 or 100.00% compared to the previous year.
Employees
30
Change (1Y)
15
Growth (1Y)
100.00%
Revenue / Employee
n/a
Profits / Employee
-$2,084,000
Market Cap
419.40M
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) | Full-Time | Part-Time |
|---|---|---|---|---|---|
| Dec 31, 2024 | 30 | 15 | 100.00% | 30 | 0 |
| Dec 31, 2023 | 15 | - | - | 14 | 1 |
Related Stocks
| Company Name | Employees |
|---|---|
| Puma Biotechnology | 172 |
| AC Immune | 172 |
| X4 Pharmaceuticals | 143 |
| Foghorn Therapeutics | 112 |
| Neumora Therapeutics | 110 |
| Aura Biosciences | 109 |
| Immuneering | 66 |
| Tectonic Therapeutic | 51 |
ZURA News
- 1 day ago - Zura Bio Appoints Immunology Industry Leader Sandeep Kulkarni, M.D. as Chief Executive Officer - Business Wire
- 10 days ago - Zura Bio Reports Business Updates and Outlook for 2026 - Business Wire
- 2 months ago - Zura Bio Reports Third Quarter 2025 Financial Results and Recent Corporate Updates - Business Wire
- 5 months ago - Zura Bio to Participate in the Cantor Fitzgerald Global Healthcare Conference - Business Wire
- 5 months ago - Zura Bio Reports Second Quarter 2025 Financial Results and Recent Corporate Updates - Business Wire
- 6 months ago - Zura Bio Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - Business Wire
- 7 months ago - Zura Bio Announces Chief Financial Officer Transition - Business Wire
- 8 months ago - Zura Bio to Present at the Jefferies Global Healthcare Conference - Business Wire